14-102507120-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152326.4(ANKRD9):c.770G>A(p.Arg257His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000917 in 1,492,982 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00057 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00096 ( 2 hom. )
Consequence
ANKRD9
NM_152326.4 missense
NM_152326.4 missense
Scores
2
1
16
Clinical Significance
Conservation
PhyloP100: 0.0790
Genes affected
ANKRD9 (HGNC:20096): (ankyrin repeat domain 9) Enables ubiquitin ligase-substrate adaptor activity. Involved in cellular copper ion homeostasis; proteasome-mediated ubiquitin-dependent protein catabolic process; and protein ubiquitination. Located in cytoplasmic vesicle and cytosol. Part of Cul5-RING ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014211088).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD9 | NM_152326.4 | c.770G>A | p.Arg257His | missense_variant | 4/4 | ENST00000286918.9 | NP_689539.1 | |
ANKRD9 | NM_001348651.2 | c.770G>A | p.Arg257His | missense_variant | 4/4 | NP_001335580.1 | ||
ANKRD9 | NM_001348652.2 | c.770G>A | p.Arg257His | missense_variant | 3/3 | NP_001335581.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD9 | ENST00000286918.9 | c.770G>A | p.Arg257His | missense_variant | 4/4 | 1 | NM_152326.4 | ENSP00000286918 | P1 | |
ANKRD9 | ENST00000559651.1 | c.770G>A | p.Arg257His | missense_variant | 2/2 | 1 | ENSP00000454100 | P1 | ||
ANKRD9 | ENST00000560748.5 | c.770G>A | p.Arg257His | missense_variant | 3/3 | 2 | ENSP00000453650 | P1 | ||
ANKRD9 | ENST00000559404.5 | c.770G>A | p.Arg257His | missense_variant | 3/3 | 2 | ENSP00000453417 |
Frequencies
GnomAD3 genomes AF: 0.000572 AC: 87AN: 152014Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
87
AN:
152014
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000637 AC: 59AN: 92684Hom.: 0 AF XY: 0.000457 AC XY: 24AN XY: 52544
GnomAD3 exomes
AF:
AC:
59
AN:
92684
Hom.:
AF XY:
AC XY:
24
AN XY:
52544
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000956 AC: 1282AN: 1340968Hom.: 2 Cov.: 30 AF XY: 0.000942 AC XY: 622AN XY: 660486
GnomAD4 exome
AF:
AC:
1282
AN:
1340968
Hom.:
Cov.:
30
AF XY:
AC XY:
622
AN XY:
660486
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000572 AC: 87AN: 152014Hom.: 0 Cov.: 32 AF XY: 0.000579 AC XY: 43AN XY: 74264
GnomAD4 genome
AF:
AC:
87
AN:
152014
Hom.:
Cov.:
32
AF XY:
AC XY:
43
AN XY:
74264
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
29
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.770G>A (p.R257H) alteration is located in exon 4 (coding exon 1) of the ANKRD9 gene. This alteration results from a G to A substitution at nucleotide position 770, causing the arginine (R) at amino acid position 257 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;.;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;.
MutationTaster
Benign
N;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;.
Polyphen
B;B;B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at